AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Edakem 1.5mg Injection

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Edaravone (1.5mg)

Overview Edakem 1.5mg Injection

Riluzole 1.5mg Injection treats amyotrophic lateral sclerosis (ALS), a debilitating neuromuscular disorder causing muscle weakness and functional impairment. This antioxidant medication mitigates nerve cell damage, potentially slowing disease progression. Administered intravenously by a healthcare provider, it's reserved for patients unable to take oral medication. Follow your physician's prescribed dosage and schedule; if a dose is missed, take it promptly upon recollection. Common side effects include headache, ecchymosis, and gait abnormalities. Injection site reactions (pain, erythema, edema) may also occur but are typically self-limiting. Persistent or bothersome side effects warrant medical consultation. Report any allergic reactions immediately—symptoms such as pruritus, facial or lingual swelling—as these demand urgent medical care.

Uses of Edakem 1.5mg Injection

Lou Gehrig's disease

Major Benefits of Edakem 1.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is not permitted.

Common Side effects of Edakem 1.5mg Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Edakem 1.5mg Injection:

The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Edakem 1.5mg Injection works:

Edakem 1.5mg Injection, an antioxidant medication, exhibits neuroprotective and cognitive-enhancing effects. Its mechanism involves mitigating neuronal damage inflicted by free radicals. Consequently, the advancement of amyotrophic lateral sclerosis (ALS) symptoms is slowed through the reduction of oxidative stress within the brain.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Edakem 1.5mg Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Edakem 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Edakem 1.5mg Injection use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

Edakem 1.5mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Edakem 1.5mg Injection to individuals with renal impairment. Seek medical advice from your physician.

LiverLiverCAUTION

The use of Edakem 1.5mg Injection requires careful monitoring in individuals with severe hepatic impairment; dosage modification may be necessary. Patient consultation with a physician is advised. Data regarding Edakem 1.5mg Injection use in such patients is limited. Dosage alteration is not suggested for those experiencing mild or moderate liver dysfunction.

What if you forget to take Edakem 1.5mg Injection :

NA

Facts to Know About Edakem 1.5mg Injection

LabelValue
Type of Compound Pyrazolone-based compounds
Addictive None.
Medication Classification Nervous system medication.
Mechanism of Action Cognitive enhancer

FAQs on Edakem 1.5mg Injection

Edakem 1.5mg Injection may cause side effects such as disorientation, cephalalgia, and gait disturbances. Less frequently reported adverse reactions encompass cutaneous hypersensitivity (manifesting as rash and pruritus), respiratory compromise (including chest constriction, wheezing, and cough, particularly in asthmatics), and mycoses.
Administered intravenously by a healthcare provider in a clinical setting, Edakem 1.5mg Injection, a liquid solution, is infused over one hour. The initial 28-day treatment cycle involves daily injections for the first fourteen days. Subsequent 28-day cycles typically consist of daily injections for the first ten days. Dosage frequency is determined by a physician based on individual patient response.
Riluzole 1.5mg injection is indicated for the management of amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease characterized by the gradual deterioration of motor neurons, leading to muscle atrophy and weakness. Riluzole 1.5mg injection exerts its therapeutic effect by decelerating the neuronal damage associated with ALS symptom progression.
Advise your physician or pharmacist of any allergies to edaravone, other drugs, sodium bisulfite, or any Edakem 1.5mg Injection component. Disclose all current and planned medications, vitamins, and supplements to your doctor. Dosage adjustments or close monitoring for adverse reactions may be necessary. Report any history of asthma, pregnancy (current or planned), or breastfeeding to your doctor. Contact your physician immediately if you conceive while undergoing edaravone treatment.
Research has yet to determine whether ALS is preventable. Nevertheless, understanding associated risk factors may lessen the likelihood of developing the condition. These factors include tobacco use and contact with pesticides and insecticides. Furthermore, evidence indicates a heightened ALS risk among military veterans.
Individuals of Caucasian and non-Hispanic descent exhibit the highest incidence of this disease. Between 5% and 10% of all cases are hereditary, resulting from parental transmission. Onset can occur at any age, though symptoms typically appear between 55 and 75 years of age. A slightly higher prevalence is observed in males compared to females; however, this disparity diminishes with increasing age. Research indicates a possible link between military service and a 1.5 to 2-fold increased risk, potentially attributable to exposure to toxins during military operations.
Studies propose that environmental toxins encountered in combat or through intense physical exertion might explain the heightened ALS incidence observed in certain veteran and athlete populations.
Initial ALS manifestations can involve muscle fasciculations in the limbs or tongue, muscle spasms, muscle rigidity (spasticity), and weakening in an arm, leg, neck, or diaphragm. Speech may become unclear and nasal, and swallowing difficulties may arise. Many first notice ALS symptoms in the hand or arm, struggling with actions like fastening clothing, writing, or using keys. Alternatively, leg weakness can be the initial symptom, leading to gait difficulties, increased tripping, or stumbling.
Edakem 1.5mg Injection
465
MRP 566
17% off